000 01350 a2200385 4500
005 20250516125212.0
264 0 _c20130709
008 201307s 0 0 eng d
022 _a1556-679X
024 7 _a10.1128/CVI.00603-12
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDimech, Wayne
245 0 0 _aInvestigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.
_h[electronic resource]
260 _bClinical and vaccine immunology : CVI
_cFeb 2013
300 _a255-61 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies, Viral
_xblood
650 0 4 _aHemagglutination Inhibition Tests
650 0 4 _aHumans
650 0 4 _aImmunoassay
_xstandards
650 0 4 _aImmunoblotting
650 0 4 _aImmunoglobulin G
_xanalysis
650 0 4 _aROC Curve
650 0 4 _aReference Standards
650 0 4 _aReference Values
650 0 4 _aRubella
_xdiagnosis
650 0 4 _aRubella virus
_ximmunology
650 0 4 _aSensitivity and Specificity
700 1 _aArachchi, Nilukshi
700 1 _aCai, Jingjing
700 1 _aSahin, Terri
700 1 _aWilson, Kim
773 0 _tClinical and vaccine immunology : CVI
_gvol. 20
_gno. 2
_gp. 255-61
856 4 0 _uhttps://doi.org/10.1128/CVI.00603-12
_zAvailable from publisher's website
999 _c22359472
_d22359472